v3.26.1
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2026
Aug. 07, 2026
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2026  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q2  
Trading Symbol ELOX  
Entity Registrant Name ELOXX PHARMACEUTICALS, INC.  
Entity Central Index Key 0001035354  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity File Number 001-31326  
Entity Tax Identification Number 84-1368850  
Entity Address, Address Line One P.O. Box 274  
Entity Address, Address Line Two 10 Court Street  
Entity Address, City or Town Arlington  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 02476  
City Area Code 781  
Local Phone Number 577-5300  
Entity Incorporation, State or Country Code DE  
Entity Shell Company false  
Entity Current Reporting Status No  
Title of 12(b) Security Common Stock, $0.01 par value per share  
Entity Interactive Data Current No  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding   4,036,459